BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25994182)

  • 1. Effect of Ganoderma lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats.
    Wang F; Zhou Z; Ren X; Wang Y; Yang R; Luo J; Strappe P
    Lipids Health Dis; 2015 May; 14():49. PubMed ID: 25994182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistant starch manipulated hyperglycemia/hyperlipidemia and related genes expression in diabetic rats.
    Zhou Z; Wang F; Ren X; Wang Y; Blanchard C
    Int J Biol Macromol; 2015 Apr; 75():316-21. PubMed ID: 25661882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice.
    Xiao C; Wu QP; Cai W; Tan JB; Yang XB; Zhang JM
    Arch Pharm Res; 2012 Oct; 35(10):1793-801. PubMed ID: 23139131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLSP and GLSP-derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis.
    Zheng G; Zhao Y; Li Z; Hua Y; Zhang J; Miao Y; Guo Y; Li L; Shi J; Dong Z; Yang S; Fan G; Ma C
    Theranostics; 2023; 13(4):1325-1341. PubMed ID: 36923537
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihyperglycemic effect of ganoderma lucidum polysaccharides on streptozotocin-induced diabetic mice.
    Li F; Zhang Y; Zhong Z
    Int J Mol Sci; 2011; 12(9):6135-45. PubMed ID: 22016649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Effect of
    Leng Y; Wang F; Chen C; Wan X; Li X; Wang H; Wang S
    Front Biosci (Landmark Ed); 2023 Feb; 28(2):23. PubMed ID: 36866546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intervention effect of ganoderma lucidum spores on the changes of XOD, MPO and SDH in the testis tissue of NIDDM rats].
    Wang SQ; Qin WB; Kang YM; Ma XR; Liu L; Liu JX; Zhang T; Zhang B; Liang YF; Wang FF
    Zhonghua Nan Ke Xue; 2008 Sep; 14(9):792-5. PubMed ID: 18998461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats.
    Li W; Zhu C; Liu T; Zhang W; Liu X; Li P; Zhu T
    Diab Vasc Dis Res; 2020; 17(6):1479164120966998. PubMed ID: 33280417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral route of mini-proinsulin-expressing Ganoderma lucidum decreases blood glucose level in streptozocin-induced diabetic rats.
    Ni T; Hu Y; Sun L; Chen X; Zhong J; Ma H; Lin Z
    Int J Mol Med; 2007 Jul; 20(1):45-51. PubMed ID: 17549387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats.
    Teng BS; Wang CD; Zhang D; Wu JS; Pan D; Pan LF; Yang HJ; Zhou P
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):166-75. PubMed ID: 22428467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway.
    Hao J; Chen C; Huang K; Huang J; Li J; Liu P; Huang H
    Eur J Pharmacol; 2014 Dec; 745():152-65. PubMed ID: 25310908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
    Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB
    J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice.
    Seto SW; Lam TY; Tam HL; Au AL; Chan SW; Wu JH; Yu PH; Leung GP; Ngai SM; Yeung JH; Leung PS; Lee SM; Kwan YW
    Phytomedicine; 2009 May; 16(5):426-36. PubMed ID: 19109000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic activity of Ganoderma lucidum polysaccharides F31 down-regulated hepatic glucose regulatory enzymes in diabetic mice.
    Xiao C; Wu Q; Zhang J; Xie Y; Cai W; Tan J
    J Ethnopharmacol; 2017 Jan; 196():47-57. PubMed ID: 27902927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of the function of islet beta and alpha cells by intervention against glucotoxicity: experiment with rats].
    He QH; Zhou YS; Wang Z; Wang S; Mou ZQ; Li J; Chi JM
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):374-7. PubMed ID: 18581888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium-containing traditional Chinese medicine, Tianmai Xiaoke Tablet improves blood glucose through activating insulin-signaling pathway and inhibiting PTP1B and PCK2 in diabetic rats.
    Zhang Q; Xiao XH; Li M; Li WH; Yu M; Zhang HB; Ping F; Wang ZX; Zheng J
    J Integr Med; 2014 May; 12(3):162-70. PubMed ID: 24735788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
    Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
    Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.
    Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
    Cell Physiol Biochem; 2016; 39(1):350-9. PubMed ID: 27352290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Cichorium intybus linn on blood glucose, lipid constituents and selected oxidative stress parameters in streptozotocin-induced diabetic rats.
    Samarghandian S; Borji A; Tabasi SH
    Cardiovasc Hematol Disord Drug Targets; 2013 Dec; 13(3):231-6. PubMed ID: 24304233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.